Neuroendovascular therapeutic devices
MIndstrong Health developed a continuous measurement system of cognition and mood. With this, we are empowered to detect cognitive changes early, and engage in early interception and care.
Minoryx is a clinical stage biotech company leading the development of new therapies for X-ALD and other Orphan CNS diseases, a group of rare diseases of genetic origin with a high unmet medical ...
NeuroPointDX, through its compound safety screening division Stemina Biomarker Discovery, has developed the leading metabolomics platform for ...
NeuroRx, Inc. is a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders.
Proniras Corporation is a preclinical-stage biotech company focused on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury that occurs following ...
Q-State has developed technologies and proprietary approaches for probing rare and genetic CNS conditions.
Developing biomarkers for neurological disorders and concussion.
Rheostat’s mission is to invent novel treatments for neurodegenerative disease through modulation of mitophagy and autophagy.
Saniona is a research and development company focused on drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain.
The company investigates small molecules to find treatments for neurodegenerative disorders like Alzheimers’disease.
Neurodegenerative Disease Treatments
Therapix Biosciences (OTCQB: THXBY; TASE: THXBY) is an Israel-headquartered emerging specialty pharmaceutical company developing unique Cannabinoid technologies in treatment of central nervous ...
Verge uses computational genomics combined with new insights into neuroscience to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.
Vivid Genomics enables pharma companies to select and stratify the right patients for their clinical trials, increasing the probability of trial success and getting to an approved drug. We use ...